Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Moran, Antoinette, Prof, Bundy, Brian, PhD, Becker, Dorothy J, Prof, DiMeglio, Linda A, MD, Gitelman, Stephen E, Prof, Goland, Robin, Prof, Greenbaum, Carla J, MD, Herold, Kevan C, Prof, Marks, Jennifer B, Prof, Raskin, Philip, Prof, Sanda, Srinath, MD, Schatz, Desmond, Prof, Wherrett, Diane K, MD, Wilson, Darrell M, Prof, Krischer, Jeffrey P, Prof, Skyler, Jay S, Prof, Pickersgill, Linda, MD, de Koning, Eelco, Prof, Ziegler, Anette-G, Prof, Böehm, Bernhard, Prof, Badenhoop, Klaus, Prof, Schloot, Nanette, MD, Bak, Jens Friis, MD, Pozzilli, Paolo, Prof, Mauricio, Didac, MD, Donath, Marc Y, Prof, Castaño, Luis, Prof, Wägner, Ana, MD, Lervang, Hans Henrik, MD, Perrild, Hans, MD, Mandrup-Poulsen, Thomas, Prof
Published in The Lancet (British edition) (01.06.2013)
Published in The Lancet (British edition) (01.06.2013)
Get full text
Journal Article